Skip to content

SION SION Operating Lease Liabilities

Operating Lease Liabilities at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.99B+29.2%
Septerna, Inc. logo
Septerna, Inc.SEPN
$20.78M-10.0%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$11.12M+43.0%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$24.68M-28.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$406.2M-9.2%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's operating lease liabilities?
SION (SION) reported operating lease liabilities of $7.06M in Q1 2026.
How has SION's operating lease liabilities changed year-over-year?
SION's operating lease liabilities decreased by 15.8% year-over-year, from $8.38M to $7.06M.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.